BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8863170)

  • 1. Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A.
    Chen F; Slife L; Kishida T; Mulvihill J; Tisherman SE; Zbar B
    J Med Genet; 1996 Aug; 33(8):716-7. PubMed ID: 8863170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Hippel-Lindau (VHL) gene analysis in Italian families with VHL disease.
    Montera M; Bellone E; Ajmar F; Mandich P
    Contrib Nephrol; 1997; 122():109-11. PubMed ID: 9399050
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular characterization and ophthalmic investigation of a large family with type 2A Von Hippel-Lindau Disease.
    Allen RC; Webster AR; Sui R; Brown J; Taylor CM; Stone EM
    Arch Ophthalmol; 2001 Nov; 119(11):1659-65. PubMed ID: 11709017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mosaicism in von Hippel-Lindau Disease.
    Murgia A; Martella M; Vinanzi C; Polli R; Perilongo G; Opocher G
    Hum Mutat; 2000 Jan; 15(1):114. PubMed ID: 10612832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
    Maher ER; Webster AR; Richards FM; Green JS; Crossey PA; Payne SJ; Moore AT
    J Med Genet; 1996 Apr; 33(4):328-32. PubMed ID: 8730290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect.
    Brauch H; Kishida T; Glavac D; Chen F; Pausch F; Höfler H; Latif F; Lerman MI; Zbar B; Neumann HP
    Hum Genet; 1995 May; 95(5):551-6. PubMed ID: 7759077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Hippel-Lindau disease type 2A in a family with a duplicated 21-base-pair in-frame insertion mutation in the VHL gene.
    Miyagawa Y; Nakazawa M; Noda Y; Ito S; Ohguro H
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):241-4. PubMed ID: 12644949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Von Hippel-Lindau disease].
    Shuin T; Ashida S; Yao M; Kanno H
    Nihon Rinsho; 2000 Jul; 58(7):1448-54. PubMed ID: 10921322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene.
    Hes F; Zewald R; Peeters T; Sijmons R; Links T; Verheij J; Matthijs G; Leguis E; Mortier G; van der Torren K; Rosman M; Lips C; Pearson P; van der Luijt R
    Hum Genet; 2000 Apr; 106(4):425-31. PubMed ID: 10830910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B
    Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
    Nesković G; Stanojević B; Palmar I; Dimitrijević B
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal abnormalities associated with a mutation of the nucleotide 683 in von Hippel-Lindau disease.
    Piermarocchi S; Lo Giudice G; Pilotto E; Bertoja E; Scaroni C; Martella M; Opocher G; Murgia A
    Graefes Arch Clin Exp Ophthalmol; 2000 Jul; 238(7):615-20. PubMed ID: 10955664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-phenotype correlation in von Hippel-Lindau syndrome.
    Friedrich CA
    Hum Mol Genet; 2001 Apr; 10(7):763-7. PubMed ID: 11257110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred.
    Iida K; Okimura Y; Takahashi K; Inomata S; Iguchi G; Kaji H; Chihara K
    Int J Mol Med; 2004 Mar; 13(3):401-4. PubMed ID: 14767570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable penetrance of familial pheochromocytoma associated with the von Hipple Lindau gene mutation, S68W. Mutations in brief no. 150. Online.
    Martin R; Hockey A; Walpole I; Goldblatt J
    Hum Mutat; 1998; 12(1):71. PubMed ID: 10627136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [File no. 41. VHL (von Hippel-Lindau). Tumor suppressor gene].
    Soussi T
    Bull Cancer; 2000 Nov; 87(11):771-2. PubMed ID: 11190567
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
    Crossey PA; Eng C; Ginalska-Malinowska M; Lennard TW; Wheeler DC; Ponder BA; Maher ER
    J Med Genet; 1995 Nov; 32(11):885-6. PubMed ID: 8592333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
    Prowse AH; Webster AR; Richards FM; Richard S; Olschwang S; Resche F; Affara NA; Maher ER
    Am J Hum Genet; 1997 Apr; 60(4):765-71. PubMed ID: 9106522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.